Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to -$3.3 million.

  • Collegium Pharmaceutical's Change in Account Payables rose 4476.78% to -$3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 16284.87%. This contributed to the annual value of -$11.3 million for FY2024, which is 32284.13% down from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's Change in Account Payables is -$3.3 million, which was up 4476.78% from -$7.0 million recorded in Q2 2025.
  • Collegium Pharmaceutical's 5-year Change in Account Payables high stood at $13.9 million for Q1 2025, and its period low was -$7.0 million during Q2 2025.
  • For the 5-year period, Collegium Pharmaceutical's Change in Account Payables averaged around -$477789.5, with its median value being -$573000.0 (2023).
  • As far as peak fluctuations go, Collegium Pharmaceutical's Change in Account Payables plummeted by 115000.0% in 2021, and later surged by 64885.65% in 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Change in Account Payables (Quarter) stood at -$3.5 million in 2021, then dropped by 17.0% to -$4.1 million in 2022, then surged by 219.6% to $5.0 million in 2023, then plummeted by 83.65% to $810000.0 in 2024, then plummeted by 505.31% to -$3.3 million in 2025.
  • Its last three reported values are -$3.3 million in Q3 2025, -$7.0 million for Q2 2025, and $13.9 million during Q1 2025.